New Delhi, September 14, 2019: Point of care testing volume has evolved and increased over the years. The growth is…
New Delhi, July 15, 2018: US-based leading molecular diagnostics company, Cepheid Inc. (a wholly owned subsidiary of Danaher, a NYSE-listed…